Besides, 10% off doesn’t often matter:
At 0-70 mg/dl the pump should suspend insulin either way. At 110-600 mg/dl the pump should ensure enough IoB by bolus, increase basal, and monitor either way. In that 70-110mg/dl the 10% MARD kind of matters for clinical decision-making, but not much. 90mg/dl is about as healthy as 81 and 99.
Patients are sometimes fussy by this inaccuracy but forget the tremendous benefit of trend indicators, let alone closed loop systems. Both of these have a much much larger positive impact to health than blood glucose being 10% above or below target impacts health negatively.
CGM with <=10% MARD, whether in wrist form factor or sensor form, is good enough for treatment. Of course, same as most readers, I have my doubts about this article.
Until then, Freestyle with Omnipod Dash in a close loop with iAPS was a game changer for me: Almost no peaks anymore, HBA1c on the level of a non diabetic person…
Nevertheless, good luck in productising it and I’ll be certainly trying it once it’s available…
In my experience, the quality control isn't very good (some patches will read much more accurately than others) and accuracy isn't that good when you get out of normal ranges.
I don't think the "invasive" nature of the Freestyle is a problem at all, but it would be nice to see some innovation on either the cost or the accuracy or both.
In no way would I describe CGM as solved, and this would go a long way towards filling many of the gaps, especially in younger / older / less compliant patient populations.
Main points are (fsl2 based):
- latency, currently 10min.
- accuracy, fine in normal range, but when you have a low blood sugar suddenly the latency spikes a lot.
- values when being under the shower too high.
- start up time of 60min could be lower.
-open up the hardware for any app to read
Indeed though, advancements in (affordable) closed loop tech matter more than where the CGM is worn.
Oil slick is a skin safe tar remover and searching for that using a pummice stone was reccomended on reddit.
But also in times where we have the Libre 3 which is so tiny that you legit don’t even notice it, a CGM on your wrist is not worth the loss of accuracy for T1 I guess (assuming your insurance pays for it).
You might find this interesting: "A bi-hormonal fully closed loop system"
Disclaimer: not a doctor or biologist
In the article, the researcher claims "No other technology can provide this level of precision without direct contact with the bloodstream", so it sounds like they're claiming it's better than existing CGMs in a way that might be clinically relevant. Not sure if that's plausible or whether they are directly measuring blood glucose rather than interstitial.
Type 1 diabetic here - for what it's worth, CGMs aren't particularly invasive. At least in comparison to the many many years of finger pricking! But a smart watch solution would be cool. (I actually do get my CGM readings on my smart watch, which is really nice!)
I know Apple has also worked on this stuff in the past, but from what I remember the accuracy wasn't good enough to be safe for diabetics. I'd be really curious to see accuracy stats on this in comparison to Dexcom and Freestyle CGMs.
I would definitely be excited to use something like this, but for me, the biggest quality of life improvements for me will be continued improvements with closed loop CGM + insulin pump systems.